Contact
Please use this form to send email to PR contact of this press release:
GSK announces positive results from phase III studies for mepolizumab in severe eosinophilic asthma
TO:
Please use this form to send email to PR contact of this press release:
GSK announces positive results from phase III studies for mepolizumab in severe eosinophilic asthma
TO: